BioGrad announces Europe's 1st Private Women's Health Research Tissue Bank

• BioGrad announces Women-specific Research Tissue Bank
• Bank will focus on PCOS, endometriosis, menopause & much more
• BioGrad Founder assures to focus on women’s health

In a recent announcement by BioGrad, it has revealed the first private women’s health research tissue bank of Europe. Founded in 2014, BioGrad is a Liverpool laboratory venture that caters in the Education industry with headquarters in England.

BioGrad specialises in Laboratory Skills, Clinical Training Centre, MicroBiology, Mammilian Cell Culture, Medical Student, Duke of Edinburgh, Practical Experience, Laboratory Training, premed, Medical Courses, Human Tissue Storage, Biobanking, Diagnostic Services, Cord Blood Banking, personalised medicine, women in stem, and STEM.

In addition, Dr Natalie Kenny, the founder and chief executive officer of BioGrad stated that the facility with 10,000 sq ft of space, could lead to ‘life-changing discoveries’ while uncovering treatments and cures for specific conditions like polycystic ovarian syndrome (PCOS), endometriosis, menopause and certain types of cancers that women majorly come across within their lives.

Dr Kenny mentioned, “For far too long women’s health has been an afterthought in scientific research. At BioGrad, we are proud to be leading the charge in changing this narrative. By opening Europe’s first dedicated private women’s health research tissue bank, we are not only addressing a critical gap in medical research but also empowering women to play a direct role in advancing healthcare and patient outcomes.”

In addition, the firm has also established relationships with hospitals that includes Liverpool Women’s Hospital as well as other leading hospitals in the region of Liverpool city, safeguarding a ‘seamless and dignified’ collection process. This will help women in Europe with dealing numerous health hazards, ensuring a peaceful life.